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Most proteins essential for the biogenesis of peroxi-
somes (peroxins) that are identified to date are associ-
ated with or are integral components of the peroxisomal
membrane. A prerequisite in elucidating their function
is to determine their topology in the membrane. We have
developed a novel tool to analyze the topology of perox-
isomal membrane proteins in the yeast Hansenula poly-
morpha in vivo using the 27-kDa NIa protease subunit
from the tobacco etch virus (TEVp). TEVp specifically
cleaves peptides containing the consensus sequence,
EXXYXQ2S (tev). We show that cytosolic TEVp and per-
oxisomal TEVp.SKL are selectively active on soluble cy-
tosolic and peroxisomal tev-containing proteins in vivo,
respectively, without affecting the viability of the yeast
cells. The tev sequence was introduced in between the
primary sequence of the peroxisomal membrane pro-
teins Pex3p or Pex10p and the reporter protein en-
hanced green fluorescent protein (eGFP). Co-synthesis
of these functional tev-GFP tagged proteins with either
cytosolic TEVp or peroxisomal TEVp.SKL revealed that
the C termini of Pex3p and Pex10p are exposed to the
cytosol. Additional applications of the TEV protease to
study peroxisome biogenesis are discussed.
Peroxisomes are organelles present in all eukaryotic organ-
isms studied so far. Unlike other cellular organelles, their
function may be highly diverse, dependent on cell type and the
external stimuli the cell encounters. In plants they are involved
in photorespiration, in trypanosomes they are involved in gly-
colysis, and in fungi they are involved in the synthesis of
secondary metabolites, such as -lactam penicillins (1–3). In
yeast they are essential for the metabolism of unusual carbon
sources such as oleic acid, primary amines, purines, D-amino
acids, and methanol (4). In humans they are involved in a
variety of anabolic and catabolic pathways, including plasmalo-
gen and cholesterol biosynthesis as well as fatty acid and
purine degradation. Peroxisome malfunctioning is the cause of
severe inherited human disorders, such as Zellweger syndrome
(5, 6).
Peroxisomes do not contain DNA or a protein-synthesizing
machinery. Consequently, peroxisomal proteins are synthe-
sized on cytosolic polysomes and sorted post-translationally to
their target organelle (7). Two distinct signal sequences for
peroxisomal matrix proteins have been defined (designated as
PTSs)1, the C-terminal PTS1, SKL, and variants and the N-
terminal PTS2 (8). In general, import of peroxisomal proteins
does not involve any significant protein modification (9). Re-
cently, several genes involved in peroxisome biogenesis, so-
called PEX genes encoding peroxins, have been cloned by the
functional complementation of yeast mutant strains lacking
functional peroxisomes (10). Up to now, 23 PEX genes have
been described, and more are likely to be identified in the near
future. Data base screening has been shown to be a powerful
tool to identify human homologues of the yeast peroxins. Thir-
teen human PEX homologues have been identified, so far of
which 11 were shown to restore peroxisome biogenesis in cell
lines of patients with peroxisomal disorders (6).
Most peroxins (18 out of 23) are membrane-associated pro-
teins, either peripheral or integral. To study the specific func-
tions of these peroxisomal membrane (PM)-bound peroxins,
information about the topology of these proteins is required. In
particular, the location of functional domains, either catalytic
or domains involved in physical interactions with other pro-
teins, needs to be established to get insight into the roles of the
PM peroxins.
Biochemical techniques to discriminate between peripheral
versus integral membrane protein (differential extraction by
low salt, high salt, and sodium carbonate) and to determine the
topology of PM peroxins (protease protection assays on purified
organelles or differential permeabilization of cellular mem-
branes) have been performed on most of the PM peroxins re-
ported. In many cases, however, these procedures have not led
to unequivocal information on the topology of these PM perox-
ins. Typical examples of this include the analyses on Pex8p
(11–13), Pex10p (14–17), Pex11p (18–24), Pex14p (25–28),
Pex16p (29, 30), and Pex17p (31, 32). Therefore, we set out to
develop an alternative method to establish the topology of PM
peroxins. The basic idea was to introduce a specific, heterolo-
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gous protease in the yeast Hansenula polymorpha. Prerequi-
site is that the protease should be active on a defined amino
acid sequence not present in essential proteins of the yeast,
which can be introduced in substrate PM peroxins. Co-expres-
sion of a PM peroxin containing a protease-processing site with
a cytosolic protease in one strain or a peroxisomal protease in
another strain should reveal whether the processing site is
accessible in the cytosol or in the peroxisomal matrix. The
major advantage of such a system would be that no other
proteins need to be analyzed to determine the accessibility of
the peroxisomal matrix as it is the strain expressing the cyto-
solic variant of the protease that is the control for the strain
expressing the peroxisomal variant and vice versa.
We selected a 239-amino acid fragment of the 346-kDa to-
bacco etch virus (TEV) polyprotein containing a proteinase
activity specifically processing the consensus sequence (hep-
tapeptide) EXXYXQ(S/G) in cis and in trans (33). Cleavage
occurs between glutamine and serine or glycine. This protease
has been used for site-specific proteolysis both in vitro and in
vivo in Escherichia coli and Saccharomyces cerevisiae of sub-
strate proteins containing the consensus sequence for process-
ing (34–36).
Here, we describe the synthesis and sorting of the TEV
protease to H. polymorpha peroxisomes or the cytosol. The
protease was shown to be active in both subcellular compart-
ments without the loss of cell viability. In an in vivo applica-
tion, we show that the C termini of both Pex3p (containing a
Pex19p-interaction domain) (37–39) and Pex10p (containing a
zinc-binding domain) (14) face the cytosol. Additional applica-
tions of the TEV protease to study peroxisome biogenesis are
discussed.
EXPERIMENTAL PROCEDURES
Strains and Cultivation—H. polymorpha NCYC495 (leu1.1) and de-
rivatives (Table I) were grown at 37 °C in batch cultures in YPD (1%
yeast extract, 2% Bacto peptone, 2% glucose) or in mineral medium (40)
containing either 0.5% (w/v) glucose or 0.5% (v/v) methanol as carbon
and energy sources in combination with 0.25% (w/v) ammonium sulfate
or 0.25% (w/v) ethylamine or 0.25% (w/v) methylamine as sole nitrogen
sources. For growth on solid medium, a 0.67% (w/v) yeast nitrogen base
was used, supplemented with 1% (w/v) glucose and 2% (w/v) agar. When
required, leucine was added to the medium to a final concentration of 30
mg/liter.
Molecular Biological Techniques—E. coli DH5 and XL1blue were
used for the propagation and amplification of plasmid DNA. Recombi-
nant DNA procedures (enzyme digestion, cloning, plasmid isolation,
PCR, and Southern blotting) were performed as described (41). Trans-
formation of H. polymorpha strains and site-specific integration of
single and multiple copies of plasmid DNA in the genomic AOX or AMO
locus were performed as described (37, 42, 43).
Plasmid Constructions—The oligonucleotides and plasmids used in
this study are listed in Table II. For co-synthesis of tev-containing
substrate proteins and TEV protease (TEVp) derivatives, novel H. poly-
morpha expression vectors were constructed based on the dominant
zeocin resistance gene. Vector pHIPZ4, which contains the H. polymor-
pha alcohol oxidase promoter (PAOX) for heterologous expression, has
recently been described (44). pHIPZ5, which contains the H. polymor-
pha amine oxidase promoter (PAMO), was constructed by replacing the
PAOX locus in pHIPZ4 by a 1.0-kilobase pair NotI-BamHI DNA frag-
ment from pHIPX5 (45) containing the PAMO. A DNA fragment encoding
the 27-kDa NIa protease subunit from TEVp was obtained by PCR
using primers KN11 and KN12 introducing a HindIII, BamHI, and
start codon upstream amino acid sequence SLFKG at amino acid posi-
tion 2040 in the full-length TEV and a stop codon followed by a SalI site
downstream amino acid sequence NELVIS at amino acid position 2278
in full-length TEV. A PTS1-type signal (SKL) and a SalI site were
introduced downstream the TEVp coding region using PCR and primer
KN13. The genes encoding the TEVp-substrate molecules were con-
structed as follows. By sequential cloning steps, a DNA fragment en-
coding the Myc epitope (MEQKLISEEDL), preceded by a HindIII site,
and followed by an XhoI site (primer KN3) was fused to an XhoI site
upstream of a DNA fragment containing the TEV protease cleavage
sequence (ENLYFQ2S, abbreviated as tev) followed by a BglII site and
eGFP with a PTS1 sequence (primer combination KN2-KN14) or with-
out a PTS1 (primer combination eGFP-SalI (46)-KN14). The HindIII
site upstream and the SalI site downstream the hybrid genes (TEVp
derivatives and TEVp substrate molecules) were used for insertion into
pHIPX4 and pHIPZ4. For insertion of TEVp-derivatives into pHIPZ5,
BamHI and SalI digestions were used. For constructing the
PEX10.tev.GFP hybrid gene, a XhoI site was introduced downstream
C-terminal codon R295 of H. polymorpha PEX10 by PCR and primer
KN20 and fused to the XhoI site preceding tev-GFP. Similarly, using
PCR and primer KN15, a SalI site was introduced downstream C-
terminal codon A457 of H. polymorpha PEX3 and fused to the XhoI site
preceding tev-GFP to construct the Pex3.tev.GFP hybrid gene. The
PEX3.tev.GFP and PEX10.tev.GFP hybrid genes were inserted as
BamHI-SalI fragments into pHIPX4.
Biochemical Methods—Preparation of crude extracts of H. polymor-
pha (46), SDS-polyacrylamide gel electrophoresis (47), and Western blot
analysis (48) was performed as described; blots were probed using
specific antibodies against various H. polymorpha proteins. Polyclonal
antibodies were generated in rabbits using the 27-kDa fragment of the
TEV protease used in this study. The antibodies against GFP were a
gift from Dr. W.-H. Kunau, Bochum, Germany. Goat anti-rabbit alka-
line phosphatase and goat anti-rabbit horse radish peroxidase (Roche
Molecular Biochemicals) were used as secondary antibodies that were
detected by bromochloroindolyl phosphate/nitro blue tetrazolium
(Roche Molecular Biochemicals) or ECL (Amersham Pharmacia Bio-
tech) according to the manufacturers’ protocols.
Microscopical Procedures—Fluorescent microscopy to localize hybrid
proteins containing GFP was performed as described (46) using an
Axioskop H fluorescence microscope (Zeiss Netherlands b.v., The Neth-
erlands) equipped with a Princeton Instruments CCD camera (RTE/
CCD-1300 Y; Princeton Instruments b.v., The Netherlands). Whole
cells were fixed and prepared for electron microscopy and immunocy-
tochemistry as described previously (11). Immunolabeling was per-
formed on ultrathin sections of unicryl-embedded cells using specific
antibodies against various H. polymorpha proteins and GFP and gold-
conjugated goat anti-rabbit (GAR-gold) antibodies according to the in-
structions of the manufacturer (Amersham Pharmacia Biotech).
TABLE I
H. polymorpha strains used in this study
Strain Relevant genotype Reference
NCYC 495 H. polymorpha WT, leu1.1 derivative (60)
HF34 NCYC495::PAOX-Nmyc.tev.GFP::PAOX-TEVp This study
HF35 NCYC495::PAOX-Nmyc.tev.GFP.SKL::PAOX-TEVp This study
HF36 NCYC495::PAOX-Nmyc.tev.GFP::PAOX-TEVp.SKL This study
HF37 NCYC495::PAOX-Nmyc.tev.GFP.SKL::PAOX-TEVp.SKL This study
HF38 NCYC495::PAOX-Nmyc.tev.GFP::PAMO-TEVp This study
HF39 NCYC495::PAOX-Nmyc.tev.GFP.SKL::PAMO-TEVp This study
HF40 NCYC495::PAOX-Nmyc.tev.GFP::PAMO-TEVp.SKL This study
HF41 NCYC495::PAOX-Nmyc.tev.GFP.SKL::PAMO-TEVp.SKL This study
HF42 NCYC495::PAOX-Nmyc.tev.GFP This study
HF45 NCYC495::PAOX-Nmyc.tev.GFP.SKL This study
HF151 NCYC495::PAMO-TEVp::PAOX-PEX3.tev.GFP This study
HF153 NCYC495::PAMO-TEVp.SKL::PAOX-PEX3.tev.GFP This study
HF191 NCYC495::PAMO-TEVp::PAOX-PEX10.tev.GFP This study
HF193 NCYC495::PAMO-TEVp.SKL::PAOX-PEX10.tev.GFP This study
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The use of the TEV protease to study the principles of per-
oxisome biogenesis in H. polymorpha is critically dependent on
the following prerequisites. 1) The protein should be synthe-
sized and become active in this yeast without loss of cell via-
bility, 2) it should be active on substrate proteins in the cytosol
as well as in peroxisomes, and 3) the activity of cytosolic and
peroxisomal TEVp should be selective toward cytosolic and
peroxisomal substrate molecules. The experiments to analyze
these prerequisites are detailed below.
Construction of the Substrate Molecules Nmyc.tev.GFP Con-
taining or Lacking a PTS1—To establish the activity and sub-
cellular localization of TEVp and TEVp.SKL in H. polymorpha
in vivo, we constructed two hybrid genes encoding either a
cytosolic or a peroxisomal tev-containing substrate protein mol-
ecule (Fig. 1A). These proteins consist of an N-terminal Myc
sequence (MEQKLISEEDL) followed by the TEV proteolytic
consensus sequence (ENLYFQ2S, abbreviated as tev in text
and figures) and the reporter protein eGFP (Nmyc.tev.GFP,
cytosolic protein). In the case of the peroxisomal substrate, a
PTS1 sequence, SKL, is added at the C terminus (Nmyc.tev.
GFP.SKL). Synthesis of the TEVp substrate molecules was
controlled by the strong methanol-regulated alcohol oxidase
promoter (PAOX). The production of the hybrid proteins was
determined by Western blot analysis using antibodies directed
against GFP or the Myc epitope. Both antisera specifically
FIG. 1. Sorting of the TEVp-substrate proteins, Nmyc.tev.GFP
and Nmyc.tev.GFP.SKL. A, schematic representation of the cytosolic
and peroxisomal TEVp substrate proteins, Nmyc.tev.GFP and
Nmyc.tev.GFP.SKL. Strains HF42 (Nmyc.tev.GFP) (B and D) and
HF45 (Nmyc.tev.GFP.SKL) (C and E) were grown to the mid-
exponential growth phase in methanol-containing medium. Normaski
images (B and C, left panels), fluorescence microscopy images (B and C,
right panels), and immunolocalization of the substrate molecules using
antibodies raised against the Myc epitope (D and E) are shown.
FIG. 2. In vivo processing of the cytosolic and peroxisomal
TEVp-substrate proteins. Western blot analysis of cell-free extracts
of various strains synthesizing TEV-substrate proteins with or without
TEV protease. Lanes 1 and 2 are controls showing expression of the
TEV-substrates alone (Nmyc.tev.GFP and Nmyc.tev.GFP.SKL, respec-
tively). Lanes 3-6 show the effect on the substrate proteins when com-
bined with high level expression (by PAOX) of the TEV protease (TEVp
or TEVp.SKL) when cleavage of the Myc tag is extensive in all combi-
nations. Lanes 7-10 show that with reduced expression level (by PAMO)
of the TEV protease, the processing of the substrate proteins still occurs
when it co-localizes with the protease (lanes 7 and 10) but is virtually
absent when both proteins do not co-localize (lanes 8 and 9). Lanes 1-6,
cells grown in methanol/ammonium sulfate medium. Lane 1, Nmyc.
tev.GFP (strain HF42); lane 2, Nmyc.tev.GFP.SKL (HF45); lane 3,
Nmyc.tev.GFP and TEVp (HF34); lane 4, Nmyc.tev.GFP.SKL and
TEVp (HF35) lane 5, Nmyc.tev.GFP and TEVp.SKL (HF36); and lane 6,
Nmyc.tev.GFP.SKL and TEVp.SKL (HF37). Lanes 7-10, cells grown in
methanol/methylamine medium. Lane 7, Nmyc.tev.GFP and TEVp
(HF38); lane 8, Nmyc.tev.GFP.SKL and TEVp (HF39); lane 9,
Nmyc.tev.GFP and TEVp.SKL (HF40); and lane 10, Nmyc.tev.
GFP.SKL and TEVp.SKL (HF41). Equal amounts of protein were sep-
arated by SDS-polyacrylamide gel electrophoresis analyzed by Western
blotting using specific antisera raised against GFP (top panel), Myc
(middle panel), and TEVp (bottom panel).
TABLE II
Primers and plasmids used in this study









pHIPX4a KanR, ScLEU2, PAOX-driven expression
pHIPZ4a AmpR, ZeoR, PAOX-driven expression









a Plasmids reported in Refs. 61 and 45, respectively.
b All other plasmids first reported in this study.
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recognized a protein band of the expected size of 30 kDa in
crude extracts prepared from methanol-grown transformants
(Fig. 2, lanes 1 and 2). These protein bands were undetectable
in extracts prepared from the control host strain (data not
shown). The subcellular localization of the TEVp-substrate pro-
teins was determined by fluorescence microscopy and immuno-
cytochemistry. As shown in Fig. 1, a diffuse fluorescence was
observed in cells of the strain synthesizing Nmyc.tev.GFP (Fig.
1B), which is indicative of a cytosolic location of the protein.
Immunolabeling experiments using antibodies against the Myc
epitope confirmed that indeed this substrate molecule had ac-
cumulated in the cytosol (Fig. 1D). Also, significant labeling
was localized on the nucleus of these cells, which is however not
unexpected since this substrate molecule has a size that should
allow free passage through the nuclear pore (49, 50). In con-
trast, fluorescence was observed as bright dots in the strain
producing Nmyc.tev.GFP.SKL (Fig. 1C). The peroxisomal lo-
calization of this protein was corroborated by immunocyto-
chemical experiments (Fig. 1E) in which Myc antibody-depend-
ent labeling was exclusively located on these organelles.
Unexpectedly, the protein did not diffuse into the crystalline
AO matrix of the organelle as for instance observed for the
endogenous enzyme dihydroxyacetone synthase (51). Instead,
it accumulated in the narrow space in between the crystalline
matrix and the peroxisomal membrane (Fig. 1E), a location also
observed for endogenous catalase protein (51).
Synthesis of Cytosolic or Peroxisomal TEV-Protease Does Not
Affect H. polymorpha Viability—Two TEV protease expression
plasmids were constructed, one designed to produce cytosolic
TEVp and the other one designed to produce peroxisomal
TEVp. To this end, the active 27-kDa domain of the TEV
protease (52) was modified by introducing an initiation codon
(ATG/Met) in front of amino acid 2040 and a termination codon
(TAA) downstream amino acid 2278 of full-length TEV. For
peroxisomal targeting, the typical C-terminal PTS1 signal,
SKL, was introduced at the extreme C terminus (TEVp.SKL).
In initial experiments, expression of the TEVp variants was
controlled by the PAOX. Four strains were constructed in which
the TEVp substrate proteins were co-synthesized with either
TEVp or TEVp.SKL.
Since the TEV protease might act on any endogenous protein
containing the consensus sequence EXXYXQ2(S/G), we first
determined whether the TEV protease affected cell viability. As
shown in Fig. 2, lanes 3-6, synthesis of the TEV protease
destined for the cytosol or peroxisomes was readily demon-
strated in cells grown for 16 h in methanol-containing medium.
All four strains were viable and showed growth characteristics
in methanol-containing medium akin to the host strain. Elec-
tron microscopical analysis did not reveal any significant mor-
phological difference between cells producing either TEVp or
TEVp.SKL as compared with wild type controls (data not
shown).
Cytosolic and Peroxisomal TEV Protease Are Active in Vivo in
H. polymorpha—To determine whether the TEV protease is
active in H. polymorpha in vivo, cell-free extracts of the four
strains described above were analyzed for processing of the
TEVp-substrate proteins (Fig. 2). Western blot analysis of
these extracts probed with antibodies against GFP or the Myc
epitope revealed that in all four strains, most of the substrate
proteins were processed, reducing the size of and eliminating
the Myc epitope from these molecules (Fig. 2, lanes 3-6). These
results suggest that the TEV protease is active in H. polymor-
pha cells. However, processing of the substrate protein is also
observed when the substrate and protease were supposed to be
spatially separated. At least two possibilities may account for
this phenomenon, namely (i) processing of the substrates oc-
curs either in vitro during the preparation of the cell free
extracts or (ii) processing occurs in vivo. Since both substrate
and protease are sorted by the same pathway, the peroxisome-
destined protease might already function en route to the or-
ganelle. Similarly, the peroxisome-destined substrate molecule
might become processed by cytosolic TEVp before import into
the organelle. The possibility of processing in vitro is less likely
as it was prevented by trichloroacetic acid precipitation of
whole cells immediately after harvesting. Therefore, we anti-
cipated that the processing of the GFP substrate molecules
occurred in vivo. Two alternative experiments were designed to
limit the possible in vivo processing during sorting of GFP
substrate proteins and TEVp to different subcellular locations.
First, the expression levels of TEVp and TEVp.SKL were low-
ered through the control of weaker promoter elements while
keeping the expression of the GFP substrate molecules under
the control of the AOX promoter. As can be seen in Fig. 2, lanes
7-10, a reduced production level of the TEV protease by the
amine oxidase promoter element (PAMO) resulted in a drastic
increase in the level of unprocessed substrate protein when the
two are spatially separated in the cell (Fig. 2, lanes 8 and 9). In
contrast, when the protease and the substrate protein were
destined for the same cellular compartment, most to all of the
substrate proteins were processed (Fig. 2, lanes 7 and 10).
These data show that by lowering the level of the protease,
the processing of substrate molecules in the same subcellular
location still proceeds efficiently, whereas unwanted in vivo
processing of substrate molecules destined for a different sub-
cellular location is reduced. In a second approach, we sought to
prevent in vivo processing of spatially separated substrate
proteins and TEVp by introducing a timely separation in the
synthesis of the two proteins. To achieve this, cells producing
TEVp.SKL under the control of the PAMO together with either
FIG. 3. Synthesis of TEVp.SKL prior to that of TEVp-substrate
molecules improves the specificity of in vivo processing. Strains
HF40 (PAOX-Nmyc.tev.GFP,PAMO-TEVp.SKL (A, B, and C)) and HF41
(PAOX-Nmyc.tev.GFP.SKL,PAMO-TEVp.SKL (D)) were pregrown in glu-
cose/ethylamine-medium to induce PAMO-expressed genes (A, AMO and
TEVp.SKL, not shown). Subsequently, these cells were transferred to
methanol/ammonium sulfate-medium, thus repressing further synthe-
sis of TEVp.SKL but inducing PAOX-expressed genes (B, AOX; C,
Nmyc.tev.GFP; and D, Nmyc.tev.GFP.SKL). Prior to the shift (t  0),
PAMO-expressed genes (AMO and TEVp.SKL) are synthesized and grad-
ually decrease over time after the shift. In contrast, PAOX-expressed
genes (AOX, Nmyc.tev.GFP, and Nmyc.tev.GFP.SKL) only become de-
tectable after the shift, and the protein levels increase in time. Signif-
icant amounts of the Nmyc.tev.GFP.SKL substrate protein becomes
processed in time (indicated by the arrowhead), whereas only the unpro-
cessed Nmyc.tev.GFP is detected after the shift.
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Nmyc.tev.GFP or Nmyc.tev.GFP.SKL under the control of the
PAOX were first grown in glucose/ethylamine-containing me-
dium. Under these conditions, the PAMO is induced, and thus
TEVp.SKL is synthesized and sorted to peroxisomes. Concur-
rently, because of the presence of glucose, the PAOX, and thus
the synthesis of the GFP substrate molecule, is repressed.
Subsequently, these cells were shifted to medium containing
methanol and ammonium sulfate as the sole carbon source and
nitrogen source, respectively. Now the PAMO is fully repressed
(by NH4), and thus production of TEVp.SKL is prevented,
whereas the production of the GFP substrate proteins is now
induced (by PAOX). In a time course of 8 h of the shift of cells to
methanol/ammonium sulfate-containing medium (Fig. 3), it
can be seen that amine oxidase (an indicator for TEVp synthe-
sis) is present at t  0 and is still detectable after 8 h of growth
in methanol/NH4-containing medium. In contrast, alcohol ox-
idase is virtually absent at t  0 but is readily detectable after
1 h in methanol medium. In the strain synthesizing the cyto-
solic substrate protein (Fig. 3, -GFP, top panel), no processing
is observed at 8 h after the shift of these cells from glucose/
ethylamine to methanol/ammonium sulfate medium. In con-
trast, significant amounts (50%) of the peroxisomal GFP sub-
strate molecule were found to be processed after the shift even
after 6–8 h (Fig. 3, -GFP, bottom panel). Unprocessed perox-
isomal substrate protein, however, remained detectable
throughout the 8-h time interval. Most likely, this is attribut-
able to the development of new peroxisomes in this period that
imported Nmyc.tev.GFP.SKL under conditions that repress
TEVp.SKL production and thus was not available to the pro-
tease. These data convincingly show that accumulation of
TEVp.SKL in peroxisomes prior to the synthesis of the sub-
strate protein in the cytosol prevents in vivo processing of a
substrate molecule at a different subcellular location but will
process substrate molecules targeted to the same location.
Taken together, these data show that heterologously synthe-
sized TEVp and TEVp.SKL are active in H. polymorpha in the
cytosol and peroxisomes, respectively, and can act specifically
in these compartments. Under the experimental conditions, no
vital H. polymorpha proteins are targets for the TEVp activity.
The C Termini of the Peroxisomal Membrane Proteins
HpPex3p and HpPex10p Face the Cytosol—A potential applica-
tion of the TEV protease is the determination of the topology of
peroxisomal membrane proteins. For several of these proteins,
the data are controversial to some extent and may vary with
the method used. A typical example is Pex10p. In the yeast
Pichia pastoris, the zinc finger containing the C terminus was
reported to reside in the peroxisomal matrix (15), whereas it
was reported to face the cytosol in human cells (16, 17). Pex3p
on the other hand is a peroxisomal membrane protein of which
the C terminus has consistently been reported to face the
cytosol (53–55). Therefore, we decided to determine the local-
ization of the C termini of these two proteins in H. polymorpha
using the TEVp-based system. To this end, functional hybrid
proteins, consisting of the peroxin tagged at its C terminus to
GFP linked by a tev-processing sequence, were co-synthesized
with either TEVp or TEVp.SKL. The GFP-tagged membrane
proteins were expressed by the PAOX, and the TEV proteases
were expressed by the PAMO. The cells were grown in methanol/
methylamine-containing medium, similar to the strains ex-
pressing the soluble substrate proteins as shown in Fig. 2,
lanes 7-10. As can be seen in Fig. 4, fluorescence microscopic
analysis of these cells showed that when either Pex3.tev.GFP
or Pex10p.tev.GFP was co-expressed with TEVp.SKL, a clear
peroxisomal fluorescent staining was observed (Fig. 4, B and
D). In contrast, when these hybrid proteins were co-expressed
with cytosolic TEVp, a predominantly cytosolic fluorescent
staining was observed (Fig. 4, A and C). Western blot analyses
using crude extracts prepared of these cells confirm that in cells
producing the cytosolic TEVp, specific processing of the hybrid
proteins was observed (Fig. 5, shown for Pex3p.tev.GFP). Since
synthesis of both the hybrid protein and the TEV protease was
induced simultaneously, unprocessed Pex3p.tev.GFP was ex-
pected to be detectable in these strains. In contrast, no signif-
FIG. 4. Determination of the topology of peroxisomal mem-
brane proteins Pex3.tev.GFP and Pex10p.tev.GFP in vivo. Fluo-
rescence microscopic analysis of strains HF151 (PAMO-TEVp,PAOX-
PEX3.tev.GFP) (A), HF153 (PAMO-TEVp.SKL, PAOX-PEX3.tev.GFP) (B),
HF191 (PAMO-TEVp,PAOX-PEX10.tev.GFP) (C), and HF193 (PAMO-
TEVp.SKL,PAOX-PEX10.tev.GFP) (D) in methanol/methylamine me-
dium. Co-synthesis of Pex3p.tev.GFP (A) or Pex10.tev.GFP (C) with
cytosolic TEVp leads to a predominant cytosolic fluorescent staining,
whereas co-synthesis with peroxisomal TEVp.SKL shows a peroxisomal
rim staining for Pex3.tev.GFP (B) and Pex10.tev.GFP (D).
FIG. 5. Cytosolic TEVp processes pex3p.tev.GFP. Western
blot analysis of total protein extracts prepared from HF151 (PAMO-
TEVp,PAOX-PEX3.tev.GFP, lanes 1 and 3) and HF153 (PAMO-
TEVp.SKL, PAOX-PEX3.tev.GFP, lanes 2 and 4) cells grown in metha-
nol/methylamine medium using specific antibodies raised against H.
polymorpha Pex3p (lanes 1 and 2) or GFP (lanes 3 and 4). The arrows
indicate the hybrid protein Pex3p.tev.GFP and the processing products
Pex3p and GFP as well as endogenous Pex3p.
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icant processing of Pex3.tev.GFP was observed when it was
co-synthesized with TEVp.SKL. This result implies that the tev
site at the C terminus of Pex3p is not accessible from the
peroxisomal matrix.
DISCUSSION
In this study we describe the synthesis of the 27-kDa NIa
protease subdomain of the tobacco etch virus in the yeast H.
polymorpha. The protease was shown to be selectively active
in vivo on soluble TEVp-substrate molecules that were pro-
duced in the same compartment either in the cytosol (TEVp)
or in the peroxisomal matrix (TEVp.SKL). This system was
successfully used to show that the C termini of two peroxiso-
mal membrane proteins, Pex3p and Pex10p, face the cytosol.
Besides several other obvious applications of the TEV prote-
ase to study peroxisome biogenesis, this procedure to deter-
mine membrane protein topology seems to be pre-eminently
suited to establish the location of functional domains in PM
peroxins. To understand the function of peroxisomal membrane
proteins, knowledge of the topology of these proteins is crucial.
However, the current procedures to determine protein topology
have resulted in virtually controversial data for many (inte-
gral) peroxisomal membrane proteins, including Pex8p (11–
13), Pex10p (14–17), Pex11p (18–24), Pex14p (25–28), Pex16p
(29, 30), and Pex17p (31, 32). For example for Pex10p, these
experiments have resulted in two contradicting topologies. In
P. pastoris, the C-terminal zinc-finger domain was proposed to
face the peroxisomal matrix (15). In human cells, the C termi-
nus was proposed to face the cytosol (16, 17). Since two other
zinc-binding PM peroxins, Pex2p and Pex12p, are essential for
peroxisome biogenesis, it is important to know whether their
zinc-binding domains face the same side of the peroxisomal
membrane.
The TEV-based system was effectively used to resolve the
location of the C terminus of HpPex10p. Co-synthesis of Pex10.
tev.GFP with cytosolic TEVp resulted in cleavage of the Pex10.
tev.GFP hybrid. Cleavage was prevented when Pex10.tev.GFP
was co-synthesized with peroxisomal TEVp.SKL. Identical re-
sults were obtained with a Pex3.tev.GFP hybrid protein, the C
terminus of which is known to face the cytosol in both bakers’
yeast and human cells (53–55). These data convincingly dem-
onstrate that the C terminus of HpPex10p has the same loca-
tion as Pex3p and thus protrudes into the cytosol.
Advantages of the TEVp-processing System—The advantage
of the TEVp-based procedure over other available methods is
that no (endogenous) control proteins need to be characterized
that may display other susceptibility toward a protease or
antibody. Rather, one protein is analyzed with either a prote-
ase acting in the peroxisome or one active in the cytosol, e.g. the
strain co-expressing TEVp is the control for the TEVp.SKL
strain and vice versa. Processing can be detected in cell free
extracts and does not require organelle purification or selective
permeabilization of cellular membranes. In addition, by using a
cleavable GFP domain, processing (and thereby topology) can
be determined by fluorescence microscopy or confocal laser
scanning microscopy using living cells. Conclusive data are
obtained if only one of the combinations shows a significant
higher degree of processing as compared with the other, as
described here for Pex3.tev.GFP and Pex10.tev.GFP.
Additional Applications of the TEV Protease in Studies on
Peroxisome Biogenesis—The use of the TEV protease is clearly
not restricted to protein topology determination. Firstly, the H.
polymorpha strain expressing the peroxisomal protease is now
being used to reinitiate our efforts to set up a reliable in vitro
import system for peroxisomes. The development of such a
system has been severely hampered by both the high fragility
of peroxisomes and the lack of an unequivocal criterion for
import. Clearly, the processing of substrate molecules by the
peroxisomal TEV protease will allow an unequivocal detection
system (as for mitochondria) to monitor in vitro import of
substrate molecules. Secondly, the TEV protease will be appli-
cable in determining whether proteins exist transiently at a
different subcellular location, which in wild type cells occurs at
biochemically low or even undetectable levels. Such an ap-
proach is pre-eminently suitable to study the possible sorting of
peroxisomal membrane proteins via the endoplasmic reticulum
(56, 57) and the shuttling of the PTS1-receptor, Pex5p, between
the cytosol and the peroxisomal matrix (58, 59). Both endoplas-
mic reticulum-localized TEVp and functional HpPex5p vari-
ants that are susceptible to TEVp processing have been con-
structed in our laboratory. Thirdly, proteins containing
(internal) tev sites can be inactivated, both in vivo and in vitro,
and the effect on peroxisomal biogenesis can be studied. These
and probably other applications will further advance our
knowledge about the specific function of the peroxins.
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